Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20402Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Milionis, H. J. | en |
| dc.contributor.author | Elisaf, M. S. | en |
| dc.contributor.author | Mikhailidis, D. P. | en |
| dc.date.accessioned | 2015-11-24T19:07:07Z | - |
| dc.date.available | 2015-11-24T19:07:07Z | - |
| dc.identifier.issn | 1473-4877 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20402 | - |
| dc.rights | Default Licence | - |
| dc.subject | Age Factors | en |
| dc.subject | Aged | en |
| dc.subject | Aged, 80 and over | en |
| dc.subject | Cardiovascular Diseases/*blood/*etiology/prevention & control | en |
| dc.subject | Cholesterol, HDL/drug effects | en |
| dc.subject | Cholesterol, LDL/drug effects | en |
| dc.subject | Dyslipidemias/*blood/*complications/drug therapy | en |
| dc.subject | Humans | en |
| dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | en |
| dc.subject | Risk Assessment | en |
| dc.subject | Risk Factors | en |
| dc.title | Lipid abnormalities and cardiovascular risk in the elderly | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1185/030079908X273363 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/18218195 | - |
| heal.identifier.secondary | http://informahealthcare.com/doi/pdfplus/10.1185/030079908X273363 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2008 | - |
| heal.abstract | The relationship between dyslipidaemia and cardiovascular disease is well documented. However, it is relevant to consider that cholesterol levels vary with age. Moreover, there is some controversy regarding the ability of lipid levels to predict vascular risk beyond the age of 70 years. In general, raised low-density lipoprotein cholesterol (LDL-C) and triglyceride levels as well as reduced levels of high-density lipoprotein cholesterol (HDL-C) predict risk in the elderly. There is evidence supporting the use of statins in the elderly. It is also likely that these drugs are under-used in this population. | en |
| heal.journalName | Current Medical Research and Opinion | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Milionis-2008-Lipid abnormalities.pdf | 217.16 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
